Our technology platform consists of an automated hardware system for producing, dosing and injecting ¹⁵O-water and analytical software for processing the scan images

IMPORTANT NOTICE: MedTrace’s products are not currently cleared for routine use in any markets, including both the US and Europe. In the US, ¹⁵O-water is currently under investigation as an investigational drug in a Phase 3 clinical trial. In Europe, its use is in compliance with approvals granted by national drug authorities, in accordance with the specific legislation of each member state.